SS&C Technologies (SSNC) Analyst Day 2024 summary
Event summary combining transcript, slides, and related documents.
Analyst Day 2024 summary
20 Jan, 2026Strategic priorities and business transformation
Focus on integrating acquired businesses, product innovation, and maximizing client relationships to enhance cross-sell and upsell opportunities across 20,000+ clients and 100+ products and services.
Emphasis on R&D, with $700M annual spend and ~$2.9B invested since 2020, to drive innovation in AI, automation, and cloud-native solutions.
Expansion into new markets and geographies, including Abu Dhabi, India, Australia, and broader Asia, to capture global growth in alternatives and wealth management.
Prioritizing client satisfaction, retention, and holistic relationship management to increase net revenue retention and organic growth.
Ongoing investment in talent, learning, and diversity, with 83% of employees receiving bonuses in 2023.
Financial performance, guidance, and capital allocation
Issued medium-term organic revenue growth guidance of 4%-8% annually, with price contributing 2%-3% and margin targets of 38%-43%.
Recurring revenue represents over 80% of total, with 85% from financial services; high operating margins and strong free cash flow.
Adjusted consolidated EBITDA margin at 38.6% YTD 2024; cash flow conversion ratio averages 102% over five years.
Over $1B returned to shareholders in 2023 and YTD 2024 via buybacks and dividends; $1B buyback authorization for 2024.
Net leverage reduced to 2.8x as of Q2 2024, maintaining flexibility for future acquisitions.
Technology and innovation
Over 5,500 technologists and $700M R&D budget support 2,300+ applications, 80PB of data, and 35B API calls monthly.
AI and automation embedded across business lines, with 1,700+ digital workers deployed, 57+ AI applications in development, and $100M+ in savings delivered.
Launch of DomaniRx (pharmacy claims platform) and integration of AI in products like Intralinks Deal Center and Blue Prism for workflow automation.
Security and compliance enhanced through proprietary tools like TARVOS, and infrastructure modernization via private cloud and global data centers.
Focus on platform unification (e.g., Genesis, Trust Suite, Singularity) to deliver modular, scalable solutions across wealth, alternatives, investment management, and insurance.
Latest events from SS&C Technologies
- Q1 2026 delivered record revenue, EPS growth, and strong shareholder returns.SSNC
Q1 202623 Apr 2026 - AI-driven growth, high margins, and disciplined acquisitions fuel strong financial outlook.SSNC
47th Annual Raymond James Institutional Investor Conference21 Apr 2026 - Disciplined growth, automation, and high retention drive strong margins and future opportunities.SSNC
UBS Financial Services Conference 202612 Apr 2026 - Record performance, robust governance, and expanded equity plan headline this year's proxy.SSNC
Proxy filing8 Apr 2026 - Virtual annual meeting to vote on directors, pay, auditor, and stock plan; board recommends approval.SSNC
Proxy filing8 Apr 2026 - Record revenue, double-digit EPS growth, and robust 2026 outlook with strong cash flow.SSNC
Q4 20255 Feb 2026 - Q2 2024 saw 6.5% revenue growth, 45.6% higher net income, and a $1B buyback program.SSNC
Q2 20242 Feb 2026 - Restructured verticals, margin gains from Blue Prism, and healthcare growth via DomaniRx partnership.SSNC
2024 RBC Capital Markets Financial Technology Conference1 Feb 2026 - Strong recurring revenue and margin growth expected, driven by technology and efficiency gains.SSNC
The 44th Annual William Blair Growth Stock Conference1 Feb 2026